Home > Products > CD30 & CD64
> Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Triple Body)
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Triple Body) (CAT#: TRIB-110)
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD30 antibody are both extended with the scFv fragment from an anti-CD64 antibody. This BsAb can retarget neutrophilscells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Triple Body) (TRIB-110). Click the button below to contact us or submit your feedback about this product.